On Monday I looked at three ASX shares that brokers have given buy ratings to this week.
Unfortunately, not all shares are in favour with them right now. Three that have just been given sell ratings are listed below.
Here’s why these brokers are bearish on these ASX shares:
Adbri Ltd (ASX: ABC)
According to a note out of UBS, its analysts have retained their sell rating and lifted the price target on this building products company’s shares slightly to $2.03. The broker appears concerned by the loss of a major and long-standing supply contract with Alcoa Australia. It notes that the loss of this contract has raised questions about its lime business. The Adbri share price is changing hands for $2.25 this afternoon.
Cochlear Limited (ASX: COH)
A note out of Goldman Sachs reveals that its analysts have retained their sell rating and $159.00 price target on this hearing solutions company. Although Goldman notes that elective surgeries resumed ahead of its expectations, recent restrictions in certain regions have stifled the recovery. The broker also has concerns that more urgent elective work will be prioritised by hospitals, which could weigh on cochlear implant sales. In addition to this, it suspects that many potential users of its products may defer doing so until the pandemic passes. Especially given how many of its target market are in a higher risk age category. In light of this, it feels the market may be expecting too much from Cochlear in the medium term. The Cochlear share price is trading at $197.00 on Tuesday.
Suncorp Group Ltd (ASX: SUN)
Analysts at Credit Suisse have retained their underperform rating and $8.75 price target on this insurance and banking giant’s shares. The broker believes Suncorp could disappoint when it releases its full year results later this month. It notes pressure on both revenue and margins. In addition to this, the broker expects Suncorp to cut its final dividend by almost 80% to 9 cents per share. The Suncorp share price is currently fetching $8.78.
5 stocks under $5
We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.
And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!
*Extreme Opportunities returns as of June 5th 2020
More reading
- How will Victoria’s stage 4 lockdowns impact ASX shares?
- Why Alliance Aviation, Cochlear, Kogan, & Netwealth shares are storming higher
- ASX 200 up 0.1%: Big four banks tumble, Flight Centre sinks, SEEK cancels final dividend
- These were the worst performing shares on the ASX 200 in July
- 3 underloved ASX healthcare shares with strong comeback potential
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. The Motley Fool Australia has recommended Cochlear Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The post Leading brokers name 3 ASX shares to sell today appeared first on Motley Fool Australia.
from Motley Fool Australia https://ift.tt/39USSi3
Leave a Reply